Furthermore, FOXP3 overexpression in human cancer cell lines was shown to repress tumor growth (16,18,19) and FOXP3 was reported to be a key determinant of tumor suppression in p53-dependent responses to DNA-damaging chemotherapeutic agents (20). Here, TP53 is linked to neoplasm.